Pioglitazone And Metformin
Product Images NDC 70882-105

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone And Metformin (NDC 70882-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cambridge Therapeutics Technologies, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pioglitazone (Pioglitazone And Metformin HCl Tablets Sandoz 1)

Chemical structure of pioglitazone hydrochloride, the active ingredient in pioglitazone and metformin, shown as a molecular diagram with labeled atoms and bonds.*

FDA Label Image

Metform (Pioglitazone And Metformin HCl Tablets Sandoz 2)

Chemical structure of metformin hydrochloride showing its molecular layout including functional groups and bonding.*

FDA Label Image

Pioglitazone And Metformin Tablets, Usp 15mg/500mg (Pioglitazone And Metformin HCl Tablets Sandoz 3)

Packaging label for Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg by Cambridge Therapeutic Technologies, LLC. The label shows images of white, oval tablets marked SZ441, specifies a bottle count of 56 tablets (4 blister cards with 14 tablets each), and includes storage information and a warning about using intact blisters only. Manufacturer details and barcodes are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.